SURGICAL/CRITICAL CARE
that can damage sensitive equipment like ventilators, comput- ers and electronic devices. The solution envelops each room in a hydrogen peroxide mist
and maintains a dwell time to ensure no contaminated areas are left behind. Its hand sprayer attachment can be used to target high touchpoint areas in the room like bedrails and call bells. he disinfection process is effi cacious on even the toughest to kill hospital microbial threats like C. diff in a tri-part soil load with a 6-log reduction (99.9999%),” said Woodson. “CURoxide 7% H2O2 solution is an EPA-registered sporicidal disinfectant that is paired with the CURIS 3 device and is fea- tured on Lists K, N, and Q for use against C diff., SARS-CoV-2, Monkeypox, and more.”
Pandemic lessons learned drive disinfection innovation It has been two and half years since SARs-CoV-2, the virus responsible for COVID-19, took the healthcare world by surprise. Sharon Ward-Fore, MS, MT(ASCP), CIC, FAPIC, Infection Prevention Advisor, Metrex Infection Prevention, Envista Holdings Corporation, says the industry has learned some lessons, albeit the hard way. “One thing we learned is that we must begin now to prepare for future outbreaks and pandemics,” said Ward-Fore. “One way to do this is to consider surface disinfectants that are Environmental Protection Agency (EPA) approved to meet the Emerging Viral Pathogens (EVP) claim. When rare or novel viruses, like SARs-CoV-2 and now Monkeypox, cause outbreaks of disease, there may be few if any disinfectants that have been tested and registered for use against these specifi c pathogens. This is how we prepare for the future.” etre aviipes .0 fully ualifi es for the s claim for all virus types (enveloped, large and small non-enveloped viruses) to meet cur- rent and potentially future infection preven- tion needs, helping provide a safer environment for patients, staff and visitors. CaviWipes 2.0, which can be incorporated into daily room cleaning and disinfec- tion, features: nhanced effi cacy claims against patho- gens including Norovirus, Candida auris, and multi-drug resistant organisms (MDROs).
Metrex CaviWipes 2.0
• Excellent material compatibility with a neutral pH of 7.5, low alcohol content, and multi-pronged approach to attack and eliminate pathogens while remaining gentle on mate- rial surfaces.
asy to use label making it uick and easy to fi nd critical effi cacy, compatibility and safety information.
• Is bactericidal, tuberculocidal, virucidal and fungicidal with a 2-minute universal contact time.
Addressing HAIs throughout the healthcare continuum “Outbreaks of new and re-emerging pathogens are add- ing additional pressure on healthcare facilities,” said Emily osenberg, , enior pecialist, linical and cientifi c Affairs at CloroxPro. “Further, more care is moving to non- acute settings. Healthcare surface disinfectants need to be ready to meet the unique challenges facing infection preventionists and cleaning professionals across the healthcare continuum.” “Clorox Healthcare solutions continue to improve to meet the needs in both acute and non-acute facilities,” Rosenberg
continued. “Our ready-to-use solutions are designed to deliver fast surface disinfection effi cacy and convenience for the ever-changing demands of the healthcare environment.” Clorox Healthcare products have been formulated to meet the evolving healthcare landscape. Each of the ready-to-use, 1-step disinfectant wipes maintain fast disinfection effi cacy while improving surface compatibility to help drive effi ciencies across healthcare facilities without compromising patient safety. Clorox Healthcare Bleach Germicidal Wipes are a convenient sporicidal surface disinfectant built to kill nearly 60 microorganisms in three minutes or less, including . dif cile and C. auris. They deliver an improved formulation maintaining fast disinfection effi cacy when it matters most while improving surface compatibility and residue profi le.
Clorox
Healthcare Bleach
Germicidal Wipes
Clorox Healthcare Hydrogen Peroxide Cleaner Disinfectant Wipes are designed for use daily on common hospital surfaces. With better surface compatibility, less residue, and fast kill times, they are ideal for high-turnover areas. Clorox Healthcare VersaSure Cleaner Disinfectant Wipes have
low odor, low residue and high effi cacy in a -minute, alcohol- free quat wipe. They are formulated for surface compatibility and offer the versatility to use everywhere, with the assurance of broad-spectrum disinfection.
The focus on whole-room disinfection
Over the past decade, healthcare professionals have increas- ingly recognized the importance of whole-room disinfection, according to aryalice tlair, hief ommercial ffi cer, Halosil International. She states: “Awareness is improvement when it comes to room disinfec- tion. Ten years ago, the concept of whole-room disinfection was unknown. Facilities of all kinds used only manual spray and wipe methods and its widely recognized that this is not suffi cient to effectively reach and treat all surfaces against infection causing pathogens.”
“True whole-room surface decontamination must be exactly that, whole-room,” StClair continued. “This means every exposed surface must be treated, with no possibility to miss surfaces that arent always reached by electrostatic sprays or UV lights. Dry-mist fogging with the Halo Disinfection System reaches every surface, every time.” The Halo Disinfection System provides EPA registered whole room sporicidal decontami- nation at the touch of a button using dry-mist hydrogen peroxide fog- ging that doesnt wet surfaces, leave sticky residue, or harm electron- ics/supplies and requires no rinsing or wiping. Aerosolized HaloMist (5% H2O2, 0.01% silver ions) evaporates into a vapor to Halosil Halo Disinfection System
hpnonline.com • HEALTHCARE PURCHASING NEWS • September 2022 11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
